论文部分内容阅读
钙拮抗剂 (CCB)作为一线抗高血压药物，已广泛应用于合并糖尿病的高血压患者的治疗。但近年来一些前瞻性临床研究表明，与血管紧张素转化酶抑制剂 (ACEI)或利尿剂相比，钙拮抗剂治疗这种类型高血压患者具有潜在的危险性，已引起了广泛关注及争议。1 福辛普利与氨氯地平比较心血
Calcium antagonists (CCBs), as first-line antihypertensives, have been widely used in the treatment of hypertensive patients with diabetes mellitus. However, in recent years, some prospective clinical studies have shown that compared with ACE inhibitors or diuretics, calcium antagonists have potential risks in the treatment of patients with this type of hypertension and have aroused widespread concern and controversy . 1 fosinopril and amlodipine more effort